文献速递临床试验与 GCP

针对边缘型人格障碍攻击行为的机制化团体心理治疗(MAAP):多中心随机对照临床试验

A mechanism-based group psychotherapy approach to aggressive behavior (MAAP) in borderline personality disorder: a multicenter randomized controlled clinical trial.
PubMed 文献 · Trials · 2025-08-02

该多中心、确证性随机对照试验在德国7个中心比较MAAP与NSSP对边缘型人格障碍患者外向性攻击行为的疗效。两组均接受1次个体和13次团体治疗(每次1.5小时,每周两次,持续7-10周),计划招募186例患者,半数通过整群随机分配至MAAP。若MAAP优效,可纳入标准精神科治疗。

要点

  • MAAP靶向边缘型人格障碍外向性攻击行为背后的生物行为机制。
  • 在德国7个中心开展多中心、确证性随机对照试验,计划招募186例患者。
  • 两组均接受1次个体和13次团体治疗(每次1.5小时,每周两次,持续7-10周)。

核心结论

  • 若MAAP被证实优效,可纳入标准精神科治疗,填补当前治疗格局中针对边缘型人格障碍反应性攻击行为生物行为机制的空白。

研究设计与样本

  • 多中心、确证性、随机对照临床试验,在德国7个中心开展,计划招募N=186例边缘型人格障碍患者,半数通过整群随机分配至MAAP。
  • MAAP为团体形式、基于机制的抗攻击心理治疗,包含改编自辩证行为疗法和心智化治疗等多方面循证治疗元素;对照为非特异性支持性心理治疗(NSSP),聚焦心理治疗的非特异性一般因素。
  • 两组均基于1次个体和13次团体治疗(每次1.5小时,每周两次),在7-10周内完成。
  • 结局在基线、治疗后即刻以及治疗后4、12、20、24周采用生态瞬时评估、临床访谈、问卷和在线任务评估。

临床怎么用

  • 作者认为,若MAAP被证实优效,可纳入标准精神科治疗,填补当前治疗格局的空白。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High levels of trait anger and aggressive behavior are common and problematic phenomena in patients with borderline personality disorder (BPD). In BPD, patterns of reactive aggression often lead to functional impairment affecting important areas of life. Despite the high burden on individuals and their social environment, there are no specific, cost-effective treatments to reduce aggression in BPD. In previous studies, we and others have been able to infer specific biobehavioral mechanisms underlying patterns of reactive aggression in BPD that can be used as potential treatment targets. To address this, we developed a mechanism-based anti-aggression psychotherapy (MAAP) for the group setting that specifically targets the biobehavioral mechanisms underlying outward-directed aggression in BPD. A previously conducted proof-of-concept study had suggested beneficial effects for this neglected group of patients. METHODS: In this multicenter, confirmatory, randomized-controlled-clinical-trial, MAAP, which consists of multifaceted, evidence-based treatment elements adapted from other sophisticated treatment programs such as Dialectical Behavior Therapy and Mentalization-Based Treatment, is tested for efficacy against a non-specific supportive psychotherapy (NSSP) program focusing on non-specific general factors of psychotherapy at seven different sites in Germany. Both treatment arms, based on one individual and 13 group therapeutic sessions (1.5 h per session, twice a week), are delivered over a period of 7-10 weeks. A total of N = 186 patients will be recruited, half of whom will be cluster-randomized to MAAP. Outcomes are assessed at baseline, immediately, and 4, 12, 20, and 24 weeks post-treatment using ecological momentary assessment, clinical interviews, questionnaires, and online tasks. DISCUSSION: If proven superior, MAAP can be incorporated into standard psychiatric care, filling a critical gap in the current therapeutic landscape by offering a structured, cost-effective, and evidence-based treatment that directly targets the biobehavioral mechanisms underlying reactive aggression in BPD. By potentially improving clinical outcomes and reducing the burden of reactive aggression in BPD, MAAP could be beneficial for both individuals and their social environments. The study's large, multicenter design enhances the generalizability of the results, making them more relevant for broader clinical applications. TRIAL REGISTRATION: This study was registered in the German Clinical Trials Register DRKS (DRKS00031608) on 31.10.2023 ( https://drks.de/search/de/trial/DRKS00031608 ).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sigrist C, Bechdolf A, Bertsch K, et al. A mechanism-based group psychotherapy approach to aggressive behavior (MAAP) in borderline personality disorder: a multicenter randomized controlled clinical trial. Trials. 2025. PMID: 40753432. doi:10.1186/s13063-025-08985-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。